- call +1-201-465-4211
- email sales@mrinsights.biz
Iduronate 2 Sulfatase (Alpha L Iduronate Sulfate Sulfatase or Idursulfase or IDS or EC 3.1.6.13) pipeline Target constitutes close to 11 molecules. Out of which approximately 10 molecules are developed by companies and remaining by the universities/institutes.
Scope of the Report:
Iduronate 2-sulfatase (IDS) is a sulfatase enzyme associated with Hunter syndrome. Iduronate 2-sulfatase is required for the lysosomal degradation of heparan sulfate and dermatan sulfate. Mutations in this X-chromosome gene that result in enzymatic deficiency lead to Hunter syndrome.
The global Iduronate 2 Sulfatase market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Iduronate 2 Sulfatase.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
This report studies the Iduronate 2 Sulfatase market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Iduronate 2 Sulfatase market by product type and applications/end industries.
Market Segment by Companies, this report covers
AngioChem
ArmaGen
Bioasis Technologies
Green Cross
JCR Pharmaceuticals
Esteve
RegenxBio
Sangamo BioSciences
Shire
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Alpha L Iduronate Sulfate Sulfatase
Idursulfase
IDS
EC 3.1.6.13
Market Segment by Applications, can be divided into
Hospitals
Ambulatory Surgical Centers
Others
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Iduronate 2 Sulfatase Market Overview
1.1 Product Overview and Scope of Iduronate 2 Sulfatase
1.2 Classification of Iduronate 2 Sulfatase by Types
1.2.1 Global Iduronate 2 Sulfatase Revenue Comparison by Types (2017-2023)
1.2.2 Global Iduronate 2 Sulfatase Revenue Market Share by Types in 2017
1.2.3 Alpha L Iduronate Sulfate Sulfatase
1.2.4 Idursulfase
1.2.5 IDS
1.2.6 EC 3.1.6.13
1.3 Global Iduronate 2 Sulfatase Market by Application
1.3.1 Global Iduronate 2 Sulfatase Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.3.4 Others
1.4 Global Iduronate 2 Sulfatase Market by Regions
1.4.1 Global Iduronate 2 Sulfatase Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Iduronate 2 Sulfatase Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Iduronate 2 Sulfatase Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Iduronate 2 Sulfatase Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Iduronate 2 Sulfatase Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Iduronate 2 Sulfatase Status and Prospect (2013-2023)
1.5 Global Market Size of Iduronate 2 Sulfatase (2013-2023)
2 Manufacturers Profiles
2.1 AngioChem
2.1.1 Business Overview
2.1.2 Iduronate 2 Sulfatase Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 AngioChem Iduronate 2 Sulfatase Revenue, Gross Margin and Market Share (2016-2017)
2.2 ArmaGen
2.2.1 Business Overview
2.2.2 Iduronate 2 Sulfatase Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 ArmaGen Iduronate 2 Sulfatase Revenue, Gross Margin and Market Share (2016-2017)
2.3 Bioasis Technologies
2.3.1 Business Overview
2.3.2 Iduronate 2 Sulfatase Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Bioasis Technologies Iduronate 2 Sulfatase Revenue, Gross Margin and Market Share (2016-2017)
2.4 Green Cross
2.4.1 Business Overview
2.4.2 Iduronate 2 Sulfatase Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Green Cross Iduronate 2 Sulfatase Revenue, Gross Margin and Market Share (2016-2017)
2.5 JCR Pharmaceuticals
2.5.1 Business Overview
2.5.2 Iduronate 2 Sulfatase Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 JCR Pharmaceuticals Iduronate 2 Sulfatase Revenue, Gross Margin and Market Share (2016-2017)
2.6 Esteve
2.6.1 Business Overview
2.6.2 Iduronate 2 Sulfatase Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Esteve Iduronate 2 Sulfatase Revenue, Gross Margin and Market Share (2016-2017)
2.7 RegenxBio
2.7.1 Business Overview
2.7.2 Iduronate 2 Sulfatase Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 RegenxBio Iduronate 2 Sulfatase Revenue, Gross Margin and Market Share (2016-2017)
2.8 Sangamo BioSciences
2.8.1 Business Overview
2.8.2 Iduronate 2 Sulfatase Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Sangamo BioSciences Iduronate 2 Sulfatase Revenue, Gross Margin and Market Share (2016-2017)
2.9 Shire
2.9.1 Business Overview
2.9.2 Iduronate 2 Sulfatase Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Shire Iduronate 2 Sulfatase Revenue, Gross Margin and Market Share (2016-2017)
3 Global Iduronate 2 Sulfatase Market Competition, by Players
3.1 Global Iduronate 2 Sulfatase Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Iduronate 2 Sulfatase Players Market Share
3.2.2 Top 10 Iduronate 2 Sulfatase Players Market Share
3.3 Market Competition Trend
4 Global Iduronate 2 Sulfatase Market Size by Regions
4.1 Global Iduronate 2 Sulfatase Revenue and Market Share by Regions
4.2 North America Iduronate 2 Sulfatase Revenue and Growth Rate (2013-2018)
4.3 Europe Iduronate 2 Sulfatase Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Iduronate 2 Sulfatase Revenue and Growth Rate (2013-2018)
4.5 South America Iduronate 2 Sulfatase Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Iduronate 2 Sulfatase Revenue and Growth Rate (2013-2018)
5 North America Iduronate 2 Sulfatase Revenue by Countries
5.1 North America Iduronate 2 Sulfatase Revenue by Countries (2013-2018)
5.2 USA Iduronate 2 Sulfatase Revenue and Growth Rate (2013-2018)
5.3 Canada Iduronate 2 Sulfatase Revenue and Growth Rate (2013-2018)
5.4 Mexico Iduronate 2 Sulfatase Revenue and Growth Rate (2013-2018)
6 Europe Iduronate 2 Sulfatase Revenue by Countries
6.1 Europe Iduronate 2 Sulfatase Revenue by Countries (2013-2018)
6.2 Germany Iduronate 2 Sulfatase Revenue and Growth Rate (2013-2018)
6.3 UK Iduronate 2 Sulfatase Revenue and Growth Rate (2013-2018)
6.4 France Iduronate 2 Sulfatase Revenue and Growth Rate (2013-2018)
6.5 Russia Iduronate 2 Sulfatase Revenue and Growth Rate (2013-2018)
6.6 Italy Iduronate 2 Sulfatase Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Iduronate 2 Sulfatase Revenue by Countries
7.1 Asia-Pacific Iduronate 2 Sulfatase Revenue by Countries (2013-2018)
7.2 China Iduronate 2 Sulfatase Revenue and Growth Rate (2013-2018)
7.3 Japan Iduronate 2 Sulfatase Revenue and Growth Rate (2013-2018)
7.4 Korea Iduronate 2 Sulfatase Revenue and Growth Rate (2013-2018)
7.5 India Iduronate 2 Sulfatase Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Iduronate 2 Sulfatase Revenue and Growth Rate (2013-2018)
8 South America Iduronate 2 Sulfatase Revenue by Countries
8.1 South America Iduronate 2 Sulfatase Revenue by Countries (2013-2018)
8.2 Brazil Iduronate 2 Sulfatase Revenue and Growth Rate (2013-2018)
8.3 Argentina Iduronate 2 Sulfatase Revenue and Growth Rate (2013-2018)
8.4 Colombia Iduronate 2 Sulfatase Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Iduronate 2 Sulfatase by Countries
9.1 Middle East and Africa Iduronate 2 Sulfatase Revenue by Countries (2013-2018)
9.2 Saudi Arabia Iduronate 2 Sulfatase Revenue and Growth Rate (2013-2018)
9.3 UAE Iduronate 2 Sulfatase Revenue and Growth Rate (2013-2018)
9.4 Egypt Iduronate 2 Sulfatase Revenue and Growth Rate (2013-2018)
9.5 Nigeria Iduronate 2 Sulfatase Revenue and Growth Rate (2013-2018)
9.6 South Africa Iduronate 2 Sulfatase Revenue and Growth Rate (2013-2018)
10 Global Iduronate 2 Sulfatase Market Segment by Type
10.1 Global Iduronate 2 Sulfatase Revenue and Market Share by Type (2013-2018)
10.2 Global Iduronate 2 Sulfatase Market Forecast by Type (2018-2023)
10.3 Alpha L Iduronate Sulfate Sulfatase Revenue Growth Rate (2013-2023)
10.4 Idursulfase Revenue Growth Rate (2013-2023)
10.5 IDS Revenue Growth Rate (2013-2023)
10.6 EC 3.1.6.13 Revenue Growth Rate (2013-2023)
11 Global Iduronate 2 Sulfatase Market Segment by Application
11.1 Global Iduronate 2 Sulfatase Revenue Market Share by Application (2013-2018)
11.2 Iduronate 2 Sulfatase Market Forecast by Application (2018-2023)
11.3 Hospitals Revenue Growth (2013-2018)
11.4 Ambulatory Surgical Centers Revenue Growth (2013-2018)
11.5 Others Revenue Growth (2013-2018)
12 Global Iduronate 2 Sulfatase Market Size Forecast (2018-2023)
12.1 Global Iduronate 2 Sulfatase Market Size Forecast (2018-2023)
12.2 Global Iduronate 2 Sulfatase Market Forecast by Regions (2018-2023)
12.3 North America Iduronate 2 Sulfatase Revenue Market Forecast (2018-2023)
12.4 Europe Iduronate 2 Sulfatase Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Iduronate 2 Sulfatase Revenue Market Forecast (2018-2023)
12.6 South America Iduronate 2 Sulfatase Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Iduronate 2 Sulfatase Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Iduronate 2 Sulfatase Picture
Table Product Specifications of Iduronate 2 Sulfatase
Table Global Iduronate 2 Sulfatase and Revenue (Million USD) Market Split by Prod
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
